Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida’s KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida’s KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Mar 21 2024

Full Issue

Viewpoints: Is Chemo Always Essential In Treating Cancer?; Florida Is Fumbling The Measles Outbreak

Editorial writers discuss cancer treatment, the measles outbreak in Florida, the baby formula crisis, and more.

Chemotherapy has long been a cornerstone of treatment when it comes to fighting cancer. Although it has proven efficacy in fighting the disease, its toll on patients both mentally and physically remains profound. While the physical effects of treatment often subside, the mental strain can persist long after. (Dr. Robert Den, 3/21)

As a measles outbreak tears though Florida, the state’s surgeon general, Joseph Ladapo, is openly rejecting long-proven public health practices. He is not urging vaccination against this preventable, highly contagious, dangerous disease, and he advises parents to decide whether to keep unvaccinated kids at home. This is just the latest episode in a COVID-era pattern of peddling medical misinformation and unevidenced positions. (David Robert Grimes, /19)

More than two years after safety concerns at a major infant formula manufacturing plant sparked a nationwide shortage, two Democratic lawmakers are introducing a bill aimed at creating a more competitive, stable market for this essential product. (Alyssa Rosenberg, 3/20)

Right now in Iowa, abortion is legal until about 20 weeks with very limited exceptions, including not just the life but also the health of the mother. If the six-week abortion ban being considered again by the Iowa Supreme Court goes into effect, I'm not sure what we're going to do. (Sarah Fleming, 3/21)

From the special’s outset, Oprah made the story about GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro — a retelling of her own struggle with weight. Of course the public noticed last year when a remarkably thin Oprah emerged on red carpets. There was rampant speculation that she was on Ozempic. While Oprah never names which brand of GLP-1 she is taking, she confirmed again in this show that she is on a weight-loss drug. (Tressie McMillan Cottom, 3/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ